Article
Coumarin Derivatives as Anticancer Agents for Lung Cancer Therapy: A Review
4 Jan 2018
Abstract excerpt
BACKGROUND: The prevalence of lung cancer is 14% among the newly diagnosed cancer cases worldwide. Currently, the number of drugs that are in clinical practice is having a high prevalence of side effect and multidrug resistance. Researchers have made an attempt to expand a suitable anticancer drug that has no MDR and side effect. OBJECTIVE: Extensive exploration of Coumarin derivatives as a potent inhibitor of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
